A short course of pegylated interferon-alpha in acute HCV hepatitis.
about
Acute hepatitis C: prevention and treatmentEffective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus InfectionDiagnosis, management, and treatment of hepatitis C: an updatePharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agentsSymptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a.Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis CUse of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection.Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection.Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infectionAdherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.Hepatitis infection in the treatment of opioid dependence and abuse.Role of genetic polymorphisms in hepatitis C virus chronic infection.Acute hepatitis C virus infection in a nurse trainee following a needlestick injury.Response-guided therapy for acute hepatitis C: applying concepts from chronic treatment.Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis.Acute hepatitis C: a systematic review.Treatment of acute HCV infection.Acute hepatitis C: management in the rapidly evolving world of HCV.Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment.Intervention to improve management of acute hepatitis C infection in a UK sexual health clinic.United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015.Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin.Acute hepatitis C in Brazil: results of a national survey.European guideline for the management of hepatitis B and C virus infections, 2010.Acute Hepatitis C Infection: New Approaches to Surveillance, Treatment and Prevention
P2860
Q22305934-1167B14A-711F-4A4E-B446-B40D35C8ACE3Q27490862-F5134BE5-57CA-4A40-A579-94342C69EA2DQ29619682-588C02DD-F653-49EE-B2ED-47C6FC6359B7Q30365599-B2043575-FC83-4492-87E8-90298B2A027BQ33396464-B19734EE-0611-427A-9D2F-941320EB33CFQ33955516-AC50DA70-4051-42B8-A89F-9CF34A5D3152Q34120470-3514C0A9-8737-45FF-B0DC-320B8F2A5EF2Q34714349-8E75EB6F-A956-4B73-80BA-2F61BB9F99F2Q34779758-038B6F00-CCF6-4FDE-A6CF-F08EE519E9F6Q35053344-F45A35FD-70CC-440C-870C-BB45A9763DB4Q35389163-B6068F60-0643-4B75-A310-7ED17146A677Q35779058-8F04784E-E13E-4098-B18F-460BB4C21F7EQ36572537-254C27DB-E713-4919-BDCA-B4927BEB9BBEQ36933086-60ED20B7-3BE3-4272-97D5-1C03459B0DEEQ37161958-9EDFD148-5354-4532-8C24-F3F8C54E4576Q37162708-5E23EEA5-9FCE-4422-A8CA-9E0B215B8412Q37855530-C7C511A4-97F9-48A9-A601-6AB25B5C9A9CQ38183312-C521E4F4-F943-4333-92E4-181804A833A7Q38195262-B1078BAF-8D8E-43FD-95F0-0F2C2ED45DB4Q38611388-E953245C-EA55-4727-A72A-7BCBB3A44632Q40990518-207C3AD2-EEC4-4E62-8EDB-D9DDB946DC54Q42232261-288A9542-57CC-4220-ADBD-F01285478AB7Q45176997-8A92B8F1-383A-4856-815C-C9A15B4475EEQ45370721-61B033BE-D399-4DFD-9FEA-26B0C0B933DFQ58641902-5594F4D5-068D-4887-AAA9-00AAF35CE2FF
P2860
A short course of pegylated interferon-alpha in acute HCV hepatitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A short course of pegylated interferon-alpha in acute HCV hepatitis.
@en
A short course of pegylated interferon-alpha in acute HCV hepatitis.
@nl
type
label
A short course of pegylated interferon-alpha in acute HCV hepatitis.
@en
A short course of pegylated interferon-alpha in acute HCV hepatitis.
@nl
prefLabel
A short course of pegylated interferon-alpha in acute HCV hepatitis.
@en
A short course of pegylated interferon-alpha in acute HCV hepatitis.
@nl
P2093
P2860
P1476
A short course of pegylated interferon-alpha in acute HCV hepatitis.
@en
P2093
A Traverso
B Del Mastro
F G De Rosa
F Gaiottino
G Di Perri
O Bargiacchi
P2860
P304
P356
10.1111/J.1365-2893.2006.00802.X
P577
2007-02-01T00:00:00Z